KR-12-a5 is a non-cytotoxic agent with potent antimicrobial effects against oral pathogens

References

• Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M. 2011. Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem. 18:256–279. doi:10.2174/092986711794088399
   PubMed Web of Science ®Google Scholar
• Bedran TB, Mayer MP, Spolidorio DP, Grenier D. 2014. Synergistic anti-inflammatory activity of the antimicrobial peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts. PLoS ONE. 9:e106766. doi:10.1371/journal.pone.0106766
   PubMed Web of Science ®Google Scholar
• Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol. 3:238–250.
   PubMed Web of Science ®Google Scholar
• Byström A, Sundqvist G. 1981. Bacteriological evaluation of the efficacy of mechanical root canal instrumentation in endodontic therapy. Scand J Dent Res. 89:321–328.
   PubMedGoogle Scholar
• Chávez De Paz LE, Dahlén G, Molander A, Möller A, Bergenholtz G. 2003. Bacteria recovered from teeth with apical periodontitis after antimicrobial endodontic treatment. Int Endod J. 36:500–508. doi:10.1046/j.1365-2591.2003.00686.x
   PubMed Web of Science ®Google Scholar
• Chotjumlong P, Bolscher JG, Nazmi K, Reutrakul V, Supanchart C, Buranaphatthana W, Krisanaprakornkit S. 2013. Involvement of the P2X7 purinergic receptor and c-Jun N-terminal and extracellular signal-regulated kinases in cyclooxygenase-2 and prostaglandin E2 induction by LL-37. J Innate Immun. 5:72–83. doi:10.1159/000342928
   PubMed Web of Science ®Google Scholar
• CLSI - Clinical and Laboratory Standard Institute. 2008. Method for broth dilution antifungal susceptibility testing of yeast; approved standard. 3rd ed. Wayne, PA, CLSI document, M27-A3.
   Google Scholar
• CLSI – Clinical and Laboratory Standard Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 9thed. Wayne, PA, CLSI document, M7-A9.
   Google Scholar
• Crusca E, Rezende AA, Marchetto R, Mendes-Giannini MJS, Fontes W, Castro MS, Cilli EM. 2011. Influence of Nterminus modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide Hylina1. Biopolymers. 96:41–48. doi:10.1002/bip.v96.1
   PubMed Web of Science ®Google Scholar
• Feng X, Sambanthamoorthy K, Palys T, Paranavitana C. 2013. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. Peptides. 49:131–137. doi:10.1016/j.peptides.2013.09.007
   PubMed Web of Science ®Google Scholar
• Giangaspero A, Sandri L, Tossi A. 2001. Amphipathic alpha helical antimicrobial peptides. Eur J Biochem. 268:5589–5600. doi:10.1046/j.1432-1033.2001.02494.x
   PubMedGoogle Scholar
• Grönroos L, Mättö J, Saarela M, Luoma AR, Jousimies-Somer H, Pyhälä S, Asikainen S, Alaluusua S. 1995. Chlorhexidine susceptibilities of mutans streptococcal serotypes and ribotypes. Antimicrob Agents Chemother. 39:894–898. doi:10.1128/AAC.39.4.894
   PubMed Web of Science ®Google Scholar
• Hepso HU, Bjornland T, Skoglund LA. 1988. Sid-effects and patient acceptance of 0.2% versus 0.1% chlorhexidine used as post-operative prophylactic mouthwash. Int J Oral Maxillofac Surg. 17:17–20. doi:10.1016/S0901-5027(88)80222-4
   PubMed Web of Science ®Google Scholar
• Hope CK, Wilson M. 2004. Analysis of the effects of chlorhexidine on oral biofilm vitality and structure based on ivability profiling and an indicator of membrane integrity. Antimicrob Agents Chemother. 48:1461–1468. doi:10.1128/AAC.48.5.1461-1468.2004
   PubMed Web of Science ®Google Scholar
• Iglesias-Linares A, Yáñez-Vico RM, Sánchez-Borrego E, Moreno-Fernández AM, Solano-Reina E, Mendoza-Mendoza A. 2013. Stem cells in current paediatric dentistry practice. Arch Oral Biol. 58:227–238. doi:10.1016/j.archoralbio.2012.11.008
   PubMed Web of Science ®Google Scholar
• Jacob B, Park IS, Bang JK, Shin SY. 2013. Short KR-12 analogs designed from human cathelicidin LL37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity. J Pept Sci. 19:700–707. doi:10.1002/psc.v19.11
   PubMed Web of Science ®Google Scholar
• Järvinen H, Tenovuo J, Huovinen P. 1993. In vitro susceptibility of Streptococcus mutans to chlorhexidine and six other antimicrobial agents. Antimicrob Agents Chemother. 37:1158–1159. doi:10.1128/AAC.37.5.1158
   PubMed Web of Science ®Google Scholar
• Ji S, Hyun J, Park E, Lee BL, Kim KK, Choi Y. 2007. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res. 42:410–419. doi:10.1111/jre.2007.42.issue-5
   PubMed Web of Science ®Google Scholar
• Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem. 273:3718–3724. doi:10.1074/jbc.273.6.3718
   PubMed Web of Science ®Google Scholar
• Jönsson D, Nilsson BO. 2012. The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in human periodontal ligament cells. J Periodontal Res. 47:330–335. doi:10.1111/jre.2012.47.issue-3
   PubMed Web of Science ®Google Scholar
• Kaiser E, Colescott RL, Bossinger CD, Cook PI. 1970. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 34:595–598. doi:10.1016/0003-2697(70)90146-6
   PubMed Web of Science ®Google Scholar
• Kim EY, Rajasekaran G, Shin SY. 2017. LL-37-derived antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity. Eur J Med Chem. 18:428–441. doi:10.1016/j.ejmech.2017.05.028
   Web of Science ®Google Scholar
• Klüver E, Schulz-MarondeS Scheid S, Meyer B, Forssmann WG, Adermann K. 2005. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry. 44:9804–9816. doi:10.1021/bi050272 k
   PubMed Web of Science ®Google Scholar
• Kreling PF, Aida KL, Massunari L, Caiaffa KS, Percinoto C, Bedran TB, Spolidorio DM, Abuna GF, Cilli EM, Duque C. 2016. Cytotoxicity and the effect of cationic peptide fragments against cariogenic bacteria under planktonic and biofilm conditions. Biofouling. 32:995–1006. doi:10.1080/08927014.2016.1218850
   PubMedGoogle Scholar
• Leelakanok N, Fischer CL, Bates AM, Guthmiller JM, Johnson GK, Salem AK, Brogden KA, Brogden NK. 2015. Cytotoxicity of HBD3 for dendritic cells, normal human epidermal keratinocytes, hTERT keratinocytes, and primary oral gingival epithelial keratinocytes in cell culture conditions. Toxicol Lett. 239:90–96.
   PubMed Web of Science ®Google Scholar
• Lessa FCR, Aranha AMF, Nogueira I, Giro EMA, Hebling J, Costa CAS. 2010. Toxicity of chlorhexidine on odontoblast-like cells. J Appl Oral Sci. 18:50–58. doi:10.1590/S1678-77572010000100010
   PubMed Web of Science ®Google Scholar
• Luo Y, McLean DT, Linden GJ, McAuley DF, McMullan R, Lundy FT. 2017. The naturally occurring host defense peptide, LL-37, and its truncated mimetics KE-18 and KR-12 have selected biocidal and antibiofilm activities against Candida albicans, Staphylococcus aureus, and Escherichia coli in vitro. Front Microbiol. 31:544.
   Google Scholar
• Ma J, Wang Z, Shen Y, Haapasalo M. 2011. A new noninvasive model to study the effectiveness of dentin disinfection by using confocal laser scanning microscopy. J Endod. 37:1380–1385. doi:10.1016/j.joen.2011.06.018
   PubMed Web of Science ®Google Scholar
• Matsuzaki K. 2009. Control of cell selectivity of antimicrobial peptides. Biochimica et Biophysica Acta (BBA). Biomembranes. 1788:1687–1692. doi:10.1016/j.bbamem.2008.09.013
   Google Scholar
• Merrifield RB. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc. 2149–2154. doi:10.1021/ja00897a025
   Web of Science ®Google Scholar
• Mor A, Hani K, Nicolas PJ. 1994. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J Biol Chem. 269:31635–31641.
   PubMed Web of Science ®Google Scholar
• Nagant C, Pitts B, Nazmi K, Vandenbranden M, Bolscher JG, Stewart PS, Dehaye JP. 2012. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Antimicrob Agents Chemother. 56:5698–5708. doi:10.1128/AAC.00918-12
   PubMed Web of Science ®Google Scholar
• Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, Sayama K, Hashimoto K, Kurihara H, Sugai M. 2005. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother. 55:888–896. doi:10.1093/jac/dki103
   PubMed Web of Science ®Google Scholar
• Overhage J, Campisano A, Bains M, Torfs E, Rehm B, Hancock R. 2008. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun. 76:4176–4182. doi:10.1128/IAI.00318-08
   PubMed Web of Science ®Google Scholar
• Rosenfeld Y, Lev N, Shai Y. 2010. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides. Biochemistry. 49:853–861. doi:10.1021/bi900724x
   PubMed Web of Science ®Google Scholar
• Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB Jr, Tack BF, Vogel HJ. 2002. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem. 277:8279–8289. doi:10.1074/jbc.M108830200
   PubMed Web of Science ®Google Scholar
• Silva ACB, Stipp RN, Mattos-Graner RO, Sampaio FC. 2014. Influence of sub-lethal and lethal concentrations of chlorhexidine on morphology and glucosyltransferase genes expression in Streptococcus mutans UA159. Adv Microbiol. 4:945–954. doi:10.4236/aim.2014.413105
   Google Scholar
• Song W, Shi Y, Xiao M, Lu H, Qu T, Li P, Wu G, Tian Y. 2009. In vitro bactericidal activity of recombinant human beta-defensin-3 against pathogenic bacterial strains in humantooth root canal. Int J Antimicrob Agents. 33:237–243. doi:10.1016/j.ijantimicag.2008.05.022
   PubMed Web of Science ®Google Scholar
• Taylor K, Clarke DJ, McCullough B, Chin W, Seo E, Yang D, Oppenheim J, Uhrin D, Govan JR, Campopiano DJ, et al. 2008. Analysis and separation of residues important for chemoattractant and antimicrobial activities of beta-defensin3. J Biol Chem. 283:6631–6639. doi:10.1074/jbc.M709238200
   PubMed Web of Science ®Google Scholar
• Tjabringa GS, Ninaber DK, Drijfhout JW, Rabe KF, Hiemstra PS. 2006. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol. 140:103–112. doi:10.1159/000092305
   PubMed Web of Science ®Google Scholar
• Vandamme D, Landuyt B, Luyten W, Schoofs L. 2012. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 280:22–35. doi:10.1016/j.cellimm.2012.11.009
   PubMed Web of Science ®Google Scholar
• Wang G. 2008. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem. 283:32637–32643. doi:10.1074/jbc.M805533200
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan Y, Zhou Z, Tu H, Ren Q, Wang X, Ding L, Zhou X, Zhang L. 2017. De novo synthetic short antimicrobial peptides against cariogenic bacteria. Arch Oral Biol. 25:41–50. doi:10.1016/j.archoralbio.2017.03.017
   Web of Science ®Google Scholar
• Wiesner J, Vilcinskas A. 2010. Antimicrobial peptides – the ancient arm of the human immune system. Virulence. 1:440–464. doi:10.4161/viru.1.5.12983
   PubMed Web of Science ®Google Scholar
• Won JH, Ng TB, Legowska A, Rolka K, Hui M, Cho CH. 2011. Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans. Peptides. 32:1996–2002.
   PubMed Web of Science ®Google Scholar
• Zanatta FB, Antoniazzi RP, Rösing CK. 2007. The effect of 0.12% chlorhexidine rinsing in previously plaque-free and plaque-covered surfaces. A randomized controlled clinical trial. J Periodontol. 78:2127–2213. doi:10.1902/jop.2007.070090
   PubMed Web of Science ®Google Scholar